新的反壟斷民事訴訟司法解釋公開徵求意見稿近日將公佈
格隆匯11月17日丨最高人民法院今日舉行加強反壟斷和反不正當競爭司法新聞發佈會,最高人民法院知識產權法庭副庭長朱理稱,新的反壟斷民事訴訟司法解釋公開徵求意見稿將在近日公佈。他介紹,2022年6月24日新修改的反壟斷法通過後,爲適應反壟斷法的修改,最高人民法院加快了新的反壟斷民事訴訟司法解釋的制定。新司法解釋稿將根據修改後反壟斷法的規定和數字經濟等新業態發展狀況,重點新增有關反壟斷實體審查判斷標準和互聯網平臺行爲規制內容。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.